✨
AI Summary
- Frenelle is developing FRN01, a monthly buprenorphine injection for Opioid Use Disorder.
- FRN01 aims to overcome barriers like cost, pain, and restricted distribution of current treatments.
- Mayo Clinic Ventures backs this innovation to improve long-acting treatment accessibility.